Most medicines are developed and prescribed to a one-size-fits-all model. Perhaps then it is unsurprising that
most of them are only effective in 30-70% of patients. Because the technology to predict which medicines will
work for which patient is at a very early stage, prescribing usually follows a trial and error approach. Recent
advances in genetics and diagnostic technologies mean that in some cases it may now be possible to subgroup
patients (ie, to stratify them) according to which treatments will work best for them.
As part of an £11m programme in stratified medicines, with calls opening on 10 January 2011, the
Technology Strategy Board will invest:
 up to £5.6m in collaborative research and development projects in the field of tumour profiling and data
capture
 up to £1.5m in collaborative research and development projects that aim to develop and adopt business
models and value systems in this area Furthermore the Technology Strategy Board and Medical
Research Council (MRC) are to invest
 up to £4m in collaborative research and development projects developing biomarkers in the area of
inflammation and immunology
The Technology Strategy Board are running a set of 3 information days designed to set the scene for the
upcoming collaborative research funding call, to supply interested parties with information about the aims
of the funding call and to provide the opportunity to develop potential consortia

London - 29th November - Holiday Inn Kensington Forum

97 Cromwell Road, London SW7 4DN

Edinburgh - 6th December - Edinburgh BioQuarter, The Queen's Medical

Research Institute, 47 Little France Crescent, Edinburgh, EH16 4TJ

Manchester - 13th December - The Core Technology Facility, The University of

Manchester, 48 Grafton Street, Manchester M13 9XX

--------------------------------------------------------------------------------------------------------------------------------

To register for any of the meetings follow this link: http://www.partners4healthcare.com/index.asp

Views: 1

Add a Comment

You need to be a member of Life Sciences Scotland to add comments!

Join Life Sciences Scotland

More ways to connect

Follow Life Sciences networks on LinkedIn
GlobalScots, Nexxus, Interface, Centre for Health Science

 

Follow Life Sciences Scotland on Twitter

Latest News on our Twitter Feed

Latest Activity

Carolyn McTaggart updated an event

Get to know your market: Korea at Radisson Blu, 301 Argyle Street, Glasgow G2 8DL

June 19, 2012 from 9am to 2pm
Learn how to do business in South Korea with tips and advice on promoting your products or services overseas at this half day Smart Exporter workshop.Scottish Development International (SDI) is hosting a Korean market focus workshop on Tuesday 19 June.Howard Jang, SDI's Korean Manager, will be visiting Scotland from 11-20 June. Attend our workshop for the ideal opportunity to meet Howard Jang to answer any queries you have about doing business in South Korea.How your company can benefitFind out…See More
14 hours ago
Dr Shara Cohen posted events
18 hours ago
Dr Shara Cohen commented on Dr Shara Cohen's event '3rd Annual Miniaturisation Event - Micro Scale Bioprocess Development'
"The Deadline for abstract submissions for oral presentation is July 10th 2012 Abstracts for poster presentation only can be submitted up to two weeks before the eventPlease note that there will be a best poster prize"
18 hours ago
Dr Shara Cohen commented on Dr Shara Cohen's event 'Cell suicide is not painless for the flow cytometrist: new assays to measure cell death'
"The Deadline for abstract submissions for oral presentation is July 10th 2012 Abstracts for poster presentation only can be submitted up to two weeks before the eventPlease note that there will be a best poster prize."
18 hours ago
Dr Shara Cohen commented on Dr Shara Cohen's event '3rd Improving Immunohistochemistry Discussion Forum'
"The Deadline for early registration is July 20th 2012 After this time the fees double, so make sure you register early!"
18 hours ago
Dr Shara Cohen is attending Adaora Okechuku's event

3rd Annual Modern Challenges in Therapeutic Protein Production Event at London, United Kingdom

June 14, 2012 from 9am to 5pm
The purpose of this annual event is to look at the challenges facing therapeutic protein production and demystify some of the novel approaches and new technologies currently being developedThis event has CPD accreditation and will have a troubleshooting panel session.  Meeting Chair:  Alison Mason, MedImmune, CambridgeSee More
18 hours ago
Dr Shara Cohen commented on Dr Shara Cohen's event '3rd Annual “Induced Pluripotent Stem Cells: Production and Utility in Regenerative Medicine"'
"The Deadline for abstract submissions for oral presentation is July 10th 2012 Abstracts for poster presentation only can be submitted up to two weeks before the event"
18 hours ago
2 blog posts by Ulrike Knies-Bamforth were featured
yesterday

© 2012   Created by Siobhan McDermit.   Powered by

Badges  |  Report an Issue  |  Terms of Service